Guardant Health (GH)Director sold ~$3.6K
Meghan V. Joyce, Director at Guardant Health, sold ~$3.6K of Guardant Health shares.
- ~$3.6K
- Approx. value · 100 sh @ $35.90
- 7,548
- Holds after · shares reported
- Traded
- Dec 2, 2024
- Filed
- Dec 4, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 12, 2024Insider · 1 personInsiders: 2 sales (~$245K)
- Nov 13, 2024InsiderDirector sold ~$87K of GH shares in the open market
- Nov 18, 2024InsiderOfficer sold ~$205K of GH shares in the open market
- Dec 2, 2024 · this disclosureInsiderDirector sold ~$3.6K of GH shares in the open market
What came next
- Dec 13, 2024InsiderDirector sold ~$81K of GH shares in the open market
- Dec 18, 2024InsiderDirector sold ~$4K of GH shares in the open market
- Jan 17, 2025InsiderDirector sold ~$4.4K of GH shares in the open market
- Feb 20, 2025InsiderDirector sold ~$5.6K of GH shares in the open market
- Mar 3, 2025InsiderDirector sold ~$4.3K of GH shares in the open market
- Mar 17, 2025InsiderOfficer sold ~$151K of GH shares in the open market
- Mar 19, 2025InsiderDirector sold ~$5.1K of GH shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Guardant Health
For Guardant Health, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 23 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GH page.
Other recent filings by Meghan V. Joyce, Director
- SEC Form 4 at Guardant Health (GH)Sep 3, 2025
- SEC Form 4 at Guardant Health (GH)Jun 16, 2025
- SEC Form 4 at Guardant Health (GH)Jun 3, 2025
- SEC Form 4 at Guardant Health (GH)Mar 5, 2025
- SEC Form 4 at Guardant Health (GH)Nov 14, 2024
The full history of Meghan V. Joyce, Director is on the profile page.
How this filing works
Explore the data
Other disclosures at Guardant Health
- SEC Form 4Oct 19, 2026
- SEC Form 144Oct 16, 2026
- SEC Form 4Oct 15, 2026
- SEC Form 144Oct 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its GH page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
